Application of compound shown in formula (I) in prevention and treatment of plant bacterial diseases
By developing a compound of formula (I) that has an inhibitory effect on plant bacteria and its derivatives, the problem that the prior art is difficult to effectively prevent and treat plant bacterial diseases is solved, and effective against rice white leaf blight and citrus canker disease is achieved. Inhibition has the potential to develop novel anti-phytopathogenic bacterial drugs.
Patent Information
- Application Number
- CN202411030208.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-15
AI Technical Summary
The prior art is difficult to effectively prevent and control plant bacterial diseases, especially rice white leaf blight and citrus canker disease, and chemical pesticides have negative effects on the environment and crops.
Develop a compound of formula (I) and its derivatives for the preparation of pesticides, which have excellent inhibitory effects on plant bacteria, including its stereoisomers, solvates, hydrates, stable isotope derivatives and pesticides A scientifically acceptable salt for preventing, mitigating and treating diseases caused by plant pathogenic bacteria.
This compound has a significant inhibitory effect on rice white leaf blight pathogens and citrus canker pathogens, and has the potential to develop into a new type of anti-phytopathogenic bacterial drug, and the raw materials are easy to obtain and are easy to synthesize.
Smart Images

Figure CN118947717A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of natural medicinal chemistry, and in particular to the use of a compound represented by formula (I) in preventing and treating plant bacterial diseases. Background Art
[0002] Berberine, also known as berberine, is an isoquinoline alkaloid isolated from the traditional Chinese medicine Coptis chinensis. It is one of the main antibacterial active ingredients of Coptis chinensis and has a wide range of biological activities. It has always been favored by researchers. However, there are no reports on the use of derivatives of this compound in the prevention and treatment of plant bacterial diseases.
[0003]
[0004] Plant bacterial diseases are the most difficult to control during the growth of crops, causing serious damage to crops and huge economic losses. Rice bacterial blight can cause a 20%-50% reduction in rice production, while citrus canker seriously threatens important citrus fruit crops worldwide. Since the 1960s, the large-scale use of chemical pesticides has been one of the main methods for disease control. Although pesticides have been successful in reducing diseases, their application has a negative impact on the environment and the crops themselves. Therefore, research and development of new high-efficiency, low-toxic, and low-residue pesticides that can effectively protect and treat plant diseases is one of the main goals of pesticide development.
[0005] In view of this, the present invention is proposed. Summary of the invention
[0006] Problem that the invention aims to solve
[0007] In order to solve the above problems, the present invention provides a use of a compound represented by formula (I) in preventing and treating plant bacterial diseases. The compound represented by formula (I) exhibits excellent inhibitory effect on plant bacteria.
[0008] Solutions for solving problems
[0009] In order to solve the above technical problems, the present invention provides a use of a compound represented by formula (I) or its stereoisomers, solvates, hydrates, stable isotope derivatives and pesticide-acceptable salts in the preparation of pesticides, wherein the pesticides are used to prevent, alleviate and / or treat diseases caused by plant pathogenic bacteria:
[0010]
[0011] in:
[0012] R 1 and R 2each independently selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl;
[0013] or R 1 and R 2 and the atoms to which they are attached form a heterocyclic group or a heteroaryl group;
[0014] R 3 is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted by one or more R 3a replace;
[0015] R 4 is selected from H, D, halogen, mercapto, hydroxyl, nitro, cyano, aldehyde, alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the aldehyde, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted by one or more R 4a replace;
[0016] A - is selected from a counter anion;
[0017] The R 3a is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted by one or more R 3b replace;
[0018] The R 4a is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted by one or more R 4b replace;
[0019] The R 3b is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl;
[0020] The R 4b is selected from the group consisting of H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, haloalkyl, haloalkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl;
[0021] Provided that the compound represented by the formula (I) is not
[0022] Effects of the Invention
[0023] The compound represented by formula (I) of the present invention exhibits excellent bactericidal activity against agricultural plant bacteria, especially has a significant inhibitory effect on rice bacterial blight pathogens and citrus canker pathogens. In addition, the raw materials of the compound of formula (I) are easily available and easy to synthesize, and it has the value of further development, and is expected to be developed into a new type of anti-plant pathogenic bacteria drug. DETAILED DESCRIPTION
[0024] In order to make the technical solutions and beneficial effects of the present invention more clearly understood, the following is a detailed description by listing specific embodiments. Unless otherwise defined, the technical and scientific terms used herein have the same meanings as those in the technical field to which this application belongs.
[0025] Unless stated otherwise, the terms used in the specification and claims have the following meanings.
[0026] The term "alkyl" refers to a saturated aliphatic hydrocarbon group, which is a straight or branched chain group containing 1 to 20 carbon atoms, preferably an alkyl group containing 1 to 12 (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12) carbon atoms, and more preferably an alkyl group containing 1 to 6 carbon atoms. Non-limiting examples include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, 1-ethylpropyl, 2-methylbutyl, 3-methylbutyl, n-hexyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 2,2-dimethylbutyl, 1,3-dimethylbutyl, 2-ethylbutyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 2,3-dimethylbutyl, n-heptyl, 2-methylhexyl, 3-methylhexyl, 4-methylhexyl, 5-methylhexyl, 2, 3-Dimethylpentyl, 2,4-dimethylpentyl, 2,2-dimethylpentyl, 3,3-dimethylpentyl, 2-ethylpentyl, 3-ethylpentyl, n-octyl, 2,3-dimethylhexyl, 2,4-dimethylhexyl, 2,5-dimethylhexyl, 2,2-dimethylhexyl, 3,3-dimethylhexyl, 4,4-dimethylhexyl, 2-ethylhexyl, 3-ethylhexyl, 4-ethylhexyl, 2-methyl-2-ethylpentyl, 2-methyl-3-ethylpentyl, n-nonyl, 2-methyl-2-ethylhexyl, 2-methyl-3-ethylhexyl, 2,2-diethylpentyl, n-decyl, 3,3-diethylhexyl, 2,2-diethylhexyl, and various branched chain isomers thereof. More preferred are lower alkyl groups having 1 to 6 carbon atoms, non-limiting examples of which include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, 1-ethylpropyl, 2-methylbutyl, 3-methylbutyl, n-hexyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 2,2-dimethylbutyl, 1,3-dimethylbutyl, 2-ethylbutyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 2,3-dimethylbutyl, and the like. The alkyl group may be substituted or unsubstituted. When substituted, it may be substituted at any available point of attachment, and the substituents are preferably independently selected from one or more substituents of D atoms, halogen, alkoxy, haloalkyl, haloalkoxy, cycloalkyloxy, heterocyclyloxy, hydroxyl, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl.
[0027] The term "alkylene" refers to a saturated straight or branched aliphatic hydrocarbon group, which is a residue derived from the removal of two hydrogen atoms from the same carbon atom or two different carbon atoms of a parent alkane, and is a straight or branched group containing 1 to 20 carbon atoms, preferably 1 to 12 (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12) carbon atoms, and more preferably 1 to 6 carbon atoms. Non-limiting examples of alkylene include, but are not limited to, methylene (-CH 2 -), 1,1-ethylene (-CH(CH 3 )-), 1,2-ethylene (-CH 2 CH 2 )-、1,1-propylene(-CH(CH 2 CH 3 )-), 1,2-propylene (-CH 2 CH(CH 3 )-), 1,3-propylene (-CH 2 CH 2 CH 2 -), 1,4-butylene (-CH 2 CH 2 CH 2 CH 2 -), etc. The alkylene group may be substituted or unsubstituted, and when substituted, it may be substituted at any available attachment point, and the substituents are preferably independently and optionally selected from one or more substituents of alkenyl, alkynyl, alkoxy, haloalkoxy, cycloalkyloxy, heterocyclyloxy, alkylthio, alkylamino, halogen, mercapto, hydroxy, nitro, cyano, cycloalkyl, heterocyclyl, aryl, heteroaryl, cycloalkyloxy, heterocycloalkyloxy, cycloalkylthio, heterocycloalkylthio and oxo.
[0028] The term "alkenyl" refers to an alkyl compound containing at least one carbon-carbon double bond in the molecule, wherein the definition of alkyl is as described above. Alkenyl can be substituted or unsubstituted, and when substituted, the substituent is preferably one or more of the following groups, which are independently selected from one or more substituents in alkoxy, halogen, haloalkyl, haloalkoxy, cycloalkyloxy, heterocyclyloxy, hydroxyl, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl.
[0029] The term "alkynyl" refers to an alkyl compound containing at least one carbon-carbon triple bond in the molecule, wherein the definition of alkyl is as described above. Alkynyl can be substituted or unsubstituted, and when substituted, the substituent is preferably one or more of the following groups, which are independently selected from one or more substituents in alkoxy, halogen, haloalkyl, haloalkoxy, cycloalkyloxy, heterocyclyloxy, hydroxy, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl.
[0030] The term "cycloalkyl" refers to a saturated or partially unsaturated monocyclic or polycyclic cyclic hydrocarbon substituent, wherein the cycloalkyl ring contains 3 to 20 carbon atoms, preferably 3 to 12 carbon atoms, preferably 3 to 8 (e.g., 3, 4, 5, 6, 7, and 8) carbon atoms, and more preferably 3 to 6 carbon atoms. Non-limiting examples of monocyclic cycloalkyls include cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, cyclohexadienyl, cycloheptyl, cycloheptatrienyl, cyclooctyl, etc.; polycyclic cycloalkyls include cycloalkyls of spirocyclic, condensed, and bridged rings.
[0031] The term "spirocycloalkyl" refers to a polycyclic group of 5 to 20 yuan, a carbon atom (called spiral atom) shared between monocyclic rings, which may contain one or more double bonds. Preferably, it is 6 to 14 yuan, more preferably 7 to 10 yuan (e.g., 7, 8, 9 or 10 yuan). According to the number of spiral atoms shared between rings, the spirocycloalkyl is divided into a single spiral cycloalkyl, a double spiral cycloalkyl or a multi-spirocycloalkyl, preferably a single spiral cycloalkyl and a double spiral cycloalkyl. More preferably, it is 3 yuan / 5 yuan, 3 yuan / 6 yuan, 4 yuan / 4 yuan, 4 yuan / 5 yuan, 4 yuan / 6 yuan, 5 yuan / 5 yuan or 5 yuan / 6 yuan single spiral cycloalkyl. Non-limiting examples of spirocycloalkyl include:
[0032]
[0033] The term "condensed cycloalkyl" refers to 5 to 20 yuan, and each ring in the system shares a pair of adjacent carbon atoms with other rings in the system. All carbon polycyclic groups, wherein one or more rings can contain one or more double bonds. Preferably 6 to 14 yuan, more preferably 7 to 10 yuan (such as 7,8,9 or 10 yuan). According to the number of the composition ring, dicyclo, tricyclo, tetracycle or polycyclic condensed cycloalkyl can be divided, preferably dicyclo or tricyclo, more preferably 3 yuan / 4 yuan, 3 yuan / 5 yuan, 3 yuan / 6 yuan, 4 yuan / 4 yuan, 4 yuan / 5 yuan, 4 yuan / 6 yuan, 5 yuan / 4 yuan, 5 yuan / 5 yuan, 5 yuan / 6 yuan, 6 yuan / 3 yuan, 6 yuan / 4 yuan, 6 yuan / 5 yuan and 6 yuan / 6 yuan of dicycloalkyl. The limiting examples of condensed cycloalkyl include:
[0034]
[0035] The term "bridged cycloalkyl" refers to a 5 to 20-membered, all-carbon polycyclic group in which any two rings share two carbon atoms that are not directly connected, and which may contain one or more double bonds. Preferably, it is 6 to 14 members, and more preferably, it is 7 to 10 members (e.g., 7, 8, 9, or 10 members). According to the number of constituent rings, it can be divided into a bicyclic, tricyclic, tetracyclic, or polycyclic bridged cycloalkyl, preferably a bicyclic, tricyclic, or tetracyclic, more preferably a bicyclic or tricyclic. Non-limiting examples of bridged cycloalkyl include:
[0036]
[0037] The cycloalkyl ring includes a cycloalkyl group as described above (including a monocyclic ring, a spirocyclic ring, a condensed ring and a bridged ring) fused to an aryl, heteroaryl or heterocycloalkyl ring, wherein the ring connected to the parent structure is a cycloalkyl group, non-limiting examples include etc.; preferred
[0038] The cycloalkyl group may be substituted or unsubstituted. When substituted, it may be substituted at any available point of attachment, and the substituents are preferably independently selected from one or more substituents of halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, cycloalkyloxy, heterocyclyloxy, hydroxy, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl.
[0039] The term "alkoxy" refers to -O-(alkyl) and -O-(cycloalkyl), wherein alkyl and cycloalkyl are as defined above. Non-limiting examples of alkoxy include: methoxy, ethoxy, propoxy and butoxy. Alkoxy can be optionally substituted or unsubstituted, and when substituted, it is preferably one or more of the following groups, which are independently selected from D atoms, halogen, alkoxy, haloalkyl, haloalkoxy, cycloalkyloxy, heterocyclyloxy, hydroxyl, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl.
[0040] The term "heterocyclyl" refers to a saturated or partially unsaturated monocyclic or polycyclic non-aromatic cyclic substituent containing 3 to 20 ring atoms, one or more of which is a heteroatom selected from nitrogen, oxygen and sulfur, the sulfur being optionally oxo-substituted (i.e. forming a sulfoxide or sulfone), but excluding the ring part of -OO-, -OS- or -SS-, and the remaining ring atoms being carbon. Preferably, it contains 3 to 12 (e.g. 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12) ring atoms, of which 1 to 4 (e.g. 1, 2, 3 and 4) are heteroatoms; more preferably, it contains 3 to 8 ring atoms (e.g. 3, 4, 5, 6, 7 and 8), of which 1-3 (e.g. 1, 2 and 3) are heteroatoms; more preferably, it contains 3 to 6 ring atoms, of which 1-3 are heteroatoms; most preferably, it contains 5 or 6 ring atoms, of which 1-3 are heteroatoms. Non-limiting examples of monocyclic heterocyclyls include pyrrolidinyl, tetrahydropyranyl, 1,2,3,6-tetrahydropyridinyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, homopiperazinyl, etc. Polycyclic heterocyclyls include spiro, fused and bridged heterocyclyls.
[0041] The term "spiro heterocyclic group" refers to a non-aromatic polycyclic heterocyclic group of 5 to 20 members, one atom (called spiral atom) shared between monocyclic rings, wherein one or more ring atoms are heteroatoms selected from nitrogen, oxygen and sulfur, and the sulfur may be optionally oxoed (i.e., forming sulfoxide or sulfone), and the remaining ring atoms are carbon. It may contain one or more double bonds. It is preferably 6 to 14 members, more preferably 7 to 10 members (e.g., 7, 8, 9 or 10 members). According to the number of spiral atoms shared between rings, the spiral heterocyclic group is divided into a single spiral heterocyclic group, a double spiral heterocyclic group or a multi-spiro heterocyclic group, preferably a single spiral heterocyclic group and a double spiral heterocyclic group. It is more preferably a 3-yuan / 5-yuan, 3-yuan / 6-yuan, 4-yuan / 4-yuan, 4-yuan / 5-yuan, 4-yuan / 6-yuan, 5-yuan / 5-yuan or 5-yuan / 6-yuan single spiral heterocyclic group. Non-limiting examples of spiral heterocyclic groups include:
[0042]
[0043] The term "fused heterocyclic radical" refers to a non-aromatic polycyclic heterocyclic group of 5 to 20 yuan, each ring in the system shares a pair of atoms adjacent to other rings in the system, one or more rings may contain one or more double bonds, wherein one or more ring atoms are heteroatoms selected from nitrogen, oxygen and sulfur, and the sulfur may be optionally oxoed (i.e., forming sulfoxide or sulfone), and the remaining ring atoms are carbon. Preferably, it is 6 to 14 yuan, and more preferably 7 to 10 yuan (e.g., 7, 8, 9 or 10 yuan). According to the number of constituent rings, it can be divided into a bicyclic, tricyclic, tetracyclic or polycyclic fused heterocyclic radical, preferably a bicyclic or tricyclic, more preferably 3 yuan / 4 yuan, 3 yuan / 5 yuan, 3 yuan / 6 yuan, 4 yuan / 4 yuan, 4 yuan / 5 yuan, 4 yuan / 6 yuan, 5 yuan / 4 yuan, 5 yuan / 5 yuan, 5 yuan / 6 yuan, 6 yuan / 3 yuan, 6 yuan / 4 yuan, 6 yuan / 5 yuan and 6 yuan / 6 yuan bicyclic fused heterocyclic radical. Non-limiting examples of fused heterocyclic radicals include:
[0044]
[0045]
[0046] The term "bridged heterocyclic group" refers to a non-aromatic polycyclic heterocyclic group of 5 to 14 members, any two rings sharing two atoms that are not directly connected, which may contain one or more double bonds, wherein one or more ring atoms are heteroatoms selected from nitrogen, oxygen and sulfur, the sulfur may be optionally oxoed (i.e., forming sulfoxide or sulfone), and the remaining ring atoms are carbon. Preferably, it is 6 to 14 members, more preferably 7 to 10 members (e.g., 7, 8, 9 or 10 members). According to the number of constituent rings, it can be divided into bicyclic, tricyclic, tetracyclic or polycyclic bridged heterocyclic groups, preferably bicyclic, tricyclic or tetracyclic, more preferably bicyclic or tricyclic. Non-limiting examples of bridged heterocyclic groups include:
[0047]
[0048] The heterocyclic ring includes a heterocyclic group as described above (including a monocyclic, spiro heterocyclic, fused heterocyclic and bridged heterocyclic) fused to an aryl, heteroaryl or cycloalkyl ring, wherein the ring connected to the parent structure is a heterocyclic group, non-limiting examples of which include:
[0049] wait.
[0050] The heterocyclyl group may be substituted or unsubstituted. When substituted, it may be substituted at any available point of attachment, and the substituents are preferably independently selected from one or more substituents of halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, cycloalkyloxy, heterocyclyloxy, hydroxy, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl.
[0051] The term "aryl" refers to a 6- to 14-membered all-carbon monocyclic or fused polycyclic (fused polycyclic is a ring that shares adjacent carbon atom pairs) group with a conjugated π electron system, preferably 6- to 10-membered, such as phenyl and naphthyl. The aryl ring includes an aryl ring as described above fused to a heteroaryl, heterocyclyl or cycloalkyl ring, wherein the ring connected to the parent structure is an aryl ring, and its non-limiting examples include:
[0052]
[0053]
[0054] The aryl group may be substituted or unsubstituted. When substituted, it may be substituted at any available point of attachment, and the substituents are preferably independently selected from one or more substituents of halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, cycloalkyloxy, heterocyclyloxy, hydroxy, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl.
[0055] The term "heteroaryl" refers to a heteroaromatic system containing 1 to 4 (e.g., 1, 2, 3, and 4) heteroatoms, 5 to 14 ring atoms, wherein the heteroatoms are selected from oxygen, sulfur, and nitrogen. Heteroaryl is preferably 5 to 10 yuan (e.g., 5, 6, 7, 8, 9, or 10 yuan), more preferably 5 yuan or 6 yuan, such as furanyl, thienyl, pyridyl, pyrrolyl, N-alkylpyrrolyl, pyrimidyl, pyrazinyl, pyridazinyl, imidazolyl, pyrazolyl, triazolyl, tetrazolyl, etc. The heteroaryl ring includes a heteroaryl fused to an aryl, heterocyclyl, or cycloalkyl ring as described above, wherein the ring connected to the parent structure is a heteroaryl ring, and non-limiting examples thereof include:
[0056]
[0057] The heteroaryl group may be substituted or unsubstituted, and when substituted, it may be substituted at any available point of attachment, the substituents preferably being independently selected from one or more of halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, cycloalkyloxy, heterocyclyloxy, hydroxy, hydroxyalkyl, cyano, amino, nitro, cycloalkyl, heterocyclyl, aryl and heteroaryl.
[0058] The above-mentioned cycloalkyl, heterocyclic, aryl and heteroaryl groups include residues derived from a parent ring atom by removing one hydrogen atom, or residues derived from the same or two different ring atoms of the parent by removing two hydrogen atoms, i.e., "divalent cycloalkyl", "divalent heterocyclic", "arylene" and "heteroarylene".
[0059] The term "cycloalkyloxy" refers to a cycloalkyl-O- group in which cycloalkyl is as defined above.
[0060] The term "heterocyclyloxy" refers to heterocyclyl-O-, wherein heterocyclyl is as defined above.
[0061] The term "alkylthio" refers to an alkyl-S- group in which alkyl is as defined above.
[0062] The term "haloalkyl" refers to an alkyl group substituted with one or more halogens, wherein alkyl is as defined above.
[0063] The term "haloalkoxy" refers to an alkoxy group substituted with one or more halogens, wherein alkoxy is as defined above.
[0064] The term "hydroxyalkyl" refers to an alkyl group substituted with one or more hydroxy groups, wherein alkyl is as defined above.
[0065] The term "halogen" refers to fluorine, chlorine, bromine or iodine.
[0066] The term "hydroxy" refers to -OH.
[0067] The term "thiol" refers to -SH.
[0068] The term "amino" refers to -NH 2 .
[0069] The term "cyano" refers to -CN.
[0070] The term "nitro" refers to -NO 2 .
[0071] The term "oxo" or "oxo" refers to "=0".
[0072] In the chemical structure of the compound described in the present invention, the bond No configuration is specified, i.e., the bond Can be or include both Two configurations.
[0073] "Optional" or "optionally" means that the subsequently described event or circumstance may but need not occur, and the description includes instances where the event or circumstance occurs or does not occur. For example, "a heterocyclic group optionally substituted with an alkyl group" means that an alkyl group may but need not be present, and the description includes instances where the heterocyclic group is substituted with an alkyl group and instances where the heterocyclic group is not substituted with an alkyl group.
[0074] "Substituted" refers to one or more hydrogen atoms, preferably 1 to 5, more preferably 1 to 3 hydrogen atoms in a group, which are independently replaced by a corresponding number of substituents. Those skilled in the art can determine possible or impossible substitutions (by experiment or theory) without undue effort. For example, an amino or hydroxyl group with free hydrogen may be unstable when combined with a carbon atom with an unsaturated (such as olefinic) bond. The term "stereoisomer" refers to a compound with the same chemical structure but different arrangements of atoms or groups in space. Stereoisomers include enantiomers, diastereomers, conformational isomers (rotamers), geometric (cis / trans) isomers, atropisomers, and the like.
[0075] The term "isotopic derivative" refers to a compound whose structure differs only in the presence of one or more isotopically enriched atoms. For example, a compound having a structure of the present invention with "deuterium" or "tritium" replacing hydrogen, or with 18 F-fluorine labeling ( 18 F isotope) instead of fluorine, or with 11 C-, 13 C-, or 14 C-enriched carbon ( 11 C-, 13 C-, or 14 C-carbon labeling; 11 C-, 13 C-, or 14Compounds in which a carbon atom is replaced by a C-isotope) are within the scope of the present invention. Such compounds can be used as analytical tools or probes in, for example, biological assays, or can be used as in vivo diagnostic imaging tracers for diseases, or as tracers for pharmacodynamics, pharmacokinetics or receptor studies. The various deuterated forms of the compounds of the present invention refer to compounds in which each available hydrogen atom connected to a carbon atom can be independently replaced by a deuterium atom. Those skilled in the art can synthesize deuterated forms of compounds with reference to relevant literature. Commercially available deuterated starting materials can be used when preparing deuterated forms of compounds, or they can be synthesized using deuterated reagents using conventional techniques, and deuterated reagents include but are not limited to deuterated borane, trideuterated borane tetrahydrofuran solution, deuterated lithium aluminum hydride, deuterated iodoethane and deuterated iodomethane, etc. Deuterated substances can generally retain activity comparable to undeuterated compounds, and when deuterated at certain specific sites, better metabolic stability can be achieved, thereby obtaining certain therapeutic advantages.
[0076] The term "solvate" refers to a physical association of a compound of the invention with one or more, preferably 1-3, solvent molecules, whether organic or inorganic. The physical association includes hydrogen bonding. In some cases, for example, when one or more, preferably 1-3, solvent molecules are incorporated into the crystal lattice of a crystalline solid, the solvate will be isolated. Exemplary solvates include, but are not limited to, hydrates, ethanolates, methanolates, and isopropanolates. Solvation methods are well known in the art.
[0077] The term "agriculturally acceptable salts" means that the compounds of the present invention exist in the form of their pharmaceutically acceptable salts, including acid addition salts and base addition salts. In the present invention, agriculturally acceptable non-toxic acid addition salts refer to salts formed between the compounds of the present invention and organic or inorganic acids, including but not limited to hydrochloric acid, sulfuric acid, hydrobromic acid, hydroiodic acid, phosphoric acid, nitric acid, perchloric acid, acetic acid, oxalic acid, maleic acid, fumaric acid, tartaric acid, benzenesulfonic acid, methanesulfonic acid, salicylic acid, succinic acid, citric acid, lactic acid, propionic acid, benzoic acid, p-toluenesulfonic acid, malic acid, etc. Agriculturally acceptable non-toxic base addition salts refer to salts formed between the compounds of the present invention and organic or inorganic bases, including but not limited to alkali metal salts, such as lithium, sodium or potassium salts; alkaline earth metal salts, such as calcium or magnesium salts; organic base salts, such as ammonium salts or N-containing organic bases formed by reacting with N-containing groups. + (C 1-6 alkyl) 4 Salt.
[0078] In one aspect, the present invention provides a use of a compound represented by formula (I) or its stereoisomers, solvates, hydrates, stable isotope derivatives and pesticide-acceptable salts in the preparation of pesticides, wherein the pesticides are used to prevent, alleviate and / or treat diseases caused by plant pathogenic bacteria:
[0079]
[0080] in:
[0081] R 1 and R 2 each independently selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl;
[0082] or R 1 and R 2 and the atoms to which they are attached form a heterocyclic group or a heteroaryl group;
[0083] R 3 is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted by one or more R 3a replace;
[0084] R 4 is selected from H, D, halogen, mercapto, hydroxyl, nitro, cyano, aldehyde, alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the aldehyde, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted by one or more R 4a replace;
[0085] A - is selected from a counter anion;
[0086] The R 3a is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted by one or more R 3b replace;
[0087] The R 4a is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted by one or more R 4b replace;
[0088] The R 3b is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl;
[0089] The R 4bis selected from the group consisting of H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, haloalkyl, haloalkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl;
[0090] Provided that the compound represented by the formula (I) is not
[0091] In certain embodiments, the R 1 and R 2 Each is independently selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl.
[0092] In certain embodiments, the R 1 and R 2 Each is independently selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, C 1-3 Alkyl and C 1-3 Alkoxy.
[0093] In certain embodiments, the R 1 and R 2 Each independently selected from H, D and C 1-3 Alkoxy.
[0094] In certain embodiments, the R 1 and R 2 are each independently selected from methoxy.
[0095] In certain embodiments, the R 1 and R 2 and the atoms to which it is connected form a 3-10 membered heterocyclic group or a 5-14 membered heteroaryl group.
[0096] In certain embodiments, the R 1 and R 2 and the atoms connected thereto form a 5-10 membered heterocyclic group or a 5-10 membered heteroaryl group, wherein the 5-10 membered heterocyclic group and the 5-10 membered heteroaryl group contain 1-4 heteroatoms selected from N, O and S.
[0097] In certain embodiments, the R 1 and R 2 and the atoms connected thereto form a 5-6 membered heterocyclic group, wherein the 5-6 membered heterocyclic group contains 1-2 heteroatoms, and the heteroatoms are selected from O.
[0098] In certain embodiments, the R 1 and R2 and the atom to which it is attached to form a dioxolane group.
[0099] In certain embodiments, the R 3 Selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, C 1-20 Alkyl, C 1-20 Alkoxy, C 3-10 Cycloalkyl, 3-10 membered heterocyclic group, C 6-14 Aryl and 5-14 membered heteroaryl, the C 1-20 Alkyl, C 1-20 Alkoxy, C 3-10 Cycloalkyl, 3-10 membered heterocyclic group, C 6-14 Aryl and 5-14 membered heteroaryl are optionally substituted by one or more R 3a replace.
[0100] In certain embodiments, the R 3 Selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, C 1-10 Alkyl and C 1-10 Alkoxy, the C 1-10 Alkyl and C 1-10 The alkoxy group is optionally substituted by one or more R 3a replace.
[0101] In certain embodiments, the R 3 Selected from H, D and C 1-10 Alkyl, the C 1-10 The alkyl group is optionally substituted with one or more R 3a replace.
[0102] In certain embodiments, the R 3 is selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl and n-hexyl, wherein the methyl, ethyl, n-propyl, isopropyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl and n-hexyl are optionally substituted by one or more R 3a replace.
[0103] In certain embodiments, the R 3a is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, oxo, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl, the C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10Aryl and 5-10 membered heteroaryl are optionally substituted by one or more R 3b replace.
[0104] In certain embodiments, the R 3a Selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, C 1-6 Alkyl and C 6-10 Aryl, the C 1-6 Alkyl and C 6-10 The aryl group is optionally substituted with one or more R 3b replace.
[0105] In certain embodiments, the R 3a Selected from H, D and C 6-8 Aryl, the C 6-8 The aryl group is optionally substituted with one or more R 3b replace.
[0106] In certain embodiments, the R 3a is selected from H and phenyl, the phenyl group being optionally substituted by one or more R 3b replace.
[0107] In certain embodiments, the R 3b is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, oxo, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl.
[0108] In certain embodiments, the R 3b is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano and C 1-6 alkyl.
[0109] In certain embodiments, the R 3b Selected from H, D and C 1-4 alkyl.
[0110] In certain embodiments, the R 3b is selected from H and tert-butyl.
[0111] In certain embodiments, the R 4 Selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, aldehyde, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 3-10 membered heterocyclic group, C 6-14 Aryl and 5-14 membered heteroaryl, the aldehyde group, C 1-6 Alkyl, C 1-6 Alkoxy, C3-7 Cycloalkyl, 3-10 membered heterocyclic group, C 6-14 Aryl and 5-14 membered heteroaryl are optionally substituted by one or more R 4a replace.
[0112] In certain embodiments, the R 4 is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, aldehyde and C 1-6 Alkyl, the aldehyde group and C 1-6 The alkyl group is optionally substituted with one or more R 4a replace.
[0113] In certain embodiments, the R 4 Selected from H, D, aldehyde and C 1-3 Alkyl, the aldehyde group and C 1-3 The alkyl group is optionally substituted with one or more R 4a replace.
[0114] In certain embodiments, the R 4 is selected from H, methyl and aldehyde groups, wherein the methyl and aldehyde groups are optionally substituted by one or more R 4a replace.
[0115] In certain embodiments, the R 4a is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, oxo, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl, the C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl are optionally substituted by one or more R 4b replace.
[0116] In certain embodiments, the R 4a Selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, C 1-6 Alkyl and C 6-10 Aryl, the C 1-6 Alkyl and C 6-10 The aryl group is optionally substituted with one or more R 4b replace.
[0117] In certain embodiments, the R 4a Selected from H, D and C 6-8 Aryl, the C 6-8 The aryl group is optionally substituted with one or more R 4b replace.
[0118] In certain embodiments, the R 4a is selected from H and phenyl, the phenyl group being optionally substituted by one or more R 4b replace.
[0119] In certain embodiments, the R 4b is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, oxo, C 1-6 Alkyl, C 1-6 Alkoxy, C 1-6 Haloalkyl, C 1-6 Halogenated alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl.
[0120] In certain embodiments, the R 4b Selected from H, D, halogen, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, C 1-6 Haloalkyl and C 1-6 Halogenated alkoxy.
[0121] In certain embodiments, the R 4b Selected from H, D, halogen, cyano, C 1-3 Haloalkyl and C 1-3 Halogenated alkoxy.
[0122] In certain embodiments, the R 4b is selected from H, F, Cl, cyano, trifluoromethyl and trifluoromethoxy.
[0123] In certain embodiments, the A - Selected from the group consisting of halides, alkyl sulfates, alkyl sulfonates, phosphates, sulfates, bisulfates, lactates, glycolates, acetates and citrates.
[0124] In certain embodiments, the A - Selected from the group consisting of halides, methyl sulfate, ethyl sulfate, methane sulfonate, phosphate, sulfate, bisulfate, lactate, glycolate, acetate and citrate.
[0125] In certain embodiments, the A - Selected from chloride, bromide, iodide, phosphate, sulfate and hydrogen sulfate.
[0126] In certain embodiments, the A - Selected from chloride ions.
[0127] In certain embodiments, the compound represented by formula (I) is any of the following:
[0128]
[0129]
[0130]
[0131] In certain embodiments, the plant pathogenic bacteria are selected from Xanthomonas oryzae ACCC 11602 and Xanthomonas axonopodis pv. Citri.
[0132] On the other hand, the present invention provides a use of a pesticide composition for preventing, alleviating and / or treating diseases caused by plant pathogenic bacteria, characterized in that the pesticide composition comprises the compound represented by formula (I) or its stereoisomer, solvate, hydrate, stable isotope derivative and pesticide-acceptable salt in any of the uses described above, and a pesticide-acceptable carrier.
[0133] In certain embodiments, the plant pathogenic bacteria are selected from Xanthomonas oryzae ACCC 11602 and Xanthomonas axonopodis pv. Citri.
[0134] The term "pesticide composition" refers to a mixture containing a fungicidal effective amount of one or more of the active ingredients or their agriculturally acceptable stereoisomers, solvates, hydrates, stable isotope derivatives or salts, and other fillers and adjuvants. The purpose of preparing the active ingredients into a fungicidal composition is to more conveniently apply the pesticide to agricultural irrigation.
[0135] The term "active component", also known as "effective ingredient" or "active ingredient", refers to the key active component in the pesticide composition that has a fungicidal effect or its agriculturally acceptable stereoisomers, solvates, hydrates, stable isotope derivatives or salts. In certain embodiments of the present application, the active component of the pesticide composition comprises a compound represented by formula (I).
[0136] The term "carrier" refers to a natural or synthetic organic or inorganic compound that can be combined or associated with an active ingredient to make it easier to apply to an object (e.g., a plant, a crop, or a grass). Therefore, the carrier is preferably inert, at least agriculturally acceptable. The carrier can be solid or liquid.
[0137] On the other hand, the present invention provides a use of a pesticide preparation in preventing, alleviating and / or treating diseases caused by plant pathogenic bacteria, characterized in that the pesticide preparation comprises the compound represented by the formula (I) as described in any one of the above items or its stereoisomers, solvates, hydrates, stable isotope derivatives and pesticide-acceptable salts, or the pesticide composition as described above.
[0138] In certain embodiments, the pesticide formulation comprises the compound represented by formula (I) as described in any one of the above or its stereoisomer, solvate, hydrate, stable isotope derivative and pesticide acceptable salt as an active ingredient.
[0139] In certain embodiments, the pesticide formulation is a suspension, which includes adjuvants, including dispersants, wetting agents, thickeners, preservatives, defoamers and / or antifreeze agents, and the balance of deionized water. The dispersant is selected from one or more of glycerol fatty acid ester polyoxyethylene ether, nonionic hydroxy polyethylene oxide block copolymer, sodium lignin sulfonate, ethoxytristyrylphenol phosphate, Agrilan788 and Agrilan1015; the amount of the dispersant is 1-8% of the total weight of the formulation, such as 2-8%, preferably 3-7%, such as 3-6%, 5-6% or 3-4%; the wetting agent is selected from polyoxyethylene polyoxypropylene ether block copolymer sulfate, alkylbenzene polyoxyethylene ether phosphate, alkylphenol polyoxyethylene polyoxyethylene phosphate, etc. One or more of alkyl ether formaldehyde condensate sulfate, tristyrene polyoxyethylene ether, alkyl sodium sulfonate, sodium isopropyl naphthalene sulfonate, n-butyl naphthalene sulfonate, alkylphenol polyoxyethylene ether phosphate and phenethylphenol polyoxyethylene ether phosphate; the amount of the wetting agent is 1-6% of the total weight of the preparation, such as 2-5% or 3-4%, preferably 2-4%, such as 2-3% or 3-4%; the thickener is selected from one or more of xanthan gum, magnesium aluminum silicate and bentonite; the amount of the thickener is 0.1-5% of the total weight of the preparation, such as 0.5 -4%, 1-5%, 1-4%, 1-3% or 0.5-3%, preferably 0.5-3%, such as 1-2% or 0.5-2.5%; the preservative is selected from one or more of benzoic acid, sodium benzoate and kason, etc.; the amount of the preservative is 0.1-5% of the total weight of the preparation, such as 0.5-4%, 1-5%, 1-4%, 1-3% or 0.5-3%, preferably 0.5-3%, such as 1-2% or 0.5-2.5%; the defoamer is one or two of tributyl phosphate and silicone; the amount of the defoamer is The amount of the antifreeze agent is 0.1-3% of the total weight of the preparation, such as 0.1-2%, 0.1-1%, 0.5-1%, 0.5-2% or 0.5-3%, preferably 0.1-2%, such as 0.5-2% or 1-2.5%; the antifreeze agent is selected from one or more of ethylene glycol, propylene glycol, glycerol, urea and inorganic salts such as sodium chloride; the amount of the antifreeze agent is 0.1-10% of the total weight of the preparation, such as 1-9%, 2-8%, 1-8%, 1-7% or 1-6%, preferably 1-5%, such as 2-4% or 1-3%.
[0140] In certain embodiments, the pesticide formulation is a dry suspension, which includes adjuvants, including dispersants, wetting agents, disintegrants, binders and / or defoamers, and the rest of fillers. Among them, the dispersant is selected from one or two of 2-naphthalenesulfonic acid formaldehyde condensate and sodium lignin sulfonate; the amount of the dispersant is 1-8% of the total weight of the formulation, such as 2-8%, preferably 3-7%, such as 3-6%, 5-6% or 3-4%; the wetting agent is selected from alkylphenol polyoxyethylene ether formaldehyde condensate sulfate; the amount of the wetting agent is 1-6% of the total weight of the formulation, such as 2-5% or 3-4%, preferably 2-4%, such as 2-3% or 3-4%; the thickener is selected from one or more of xanthan gum, magnesium aluminum silicate and bentonite; the disintegrant is selected from one or more of sodium carbonate, ammonium sulfate, urea, succinic acid and sodium bicarbonate; the amount of the disintegrant is 0.1-10% of the total weight of the formulation, such as 1-9%, 1-8%, 1-7% or 1-6%, preferably 1-5%, for example 1-4% or 1-3%; the binder is selected from polyethylene glycol; the amount of the binder is 0.1-10% of the total weight of the preparation, for example 1-9%, 2-8%, 1-8%, 1-7% or 1-6%, preferably 1-5%, for example 2-4% or 1-3%; the defoamer is tributyl phosphate; the amount of the defoamer is 0.1-3% of the total weight of the preparation, for example 0.1-2%, 0.1-1%, 0.5-1%, 0.5-2% or 0.5-3%, preferably 0.1-2%, for example 0.5-2% or 0.1-1%; the filler is selected from one or more of diatomaceous earth, kaolin, white carbon, light calcium, talc, attapulgite and clay.
[0141] In certain embodiments, the pesticide formulation is a wettable powder, which includes an adjuvant, including a dispersant and / or a wetting agent, and the rest of a filler. The dispersant is selected from one or two of sodium methylnaphthalene sulfonate formaldehyde condensate and fatty amine polyoxyethylene ether; the amount of the dispersant is 1-10% of the total weight of the formulation, such as 1-9%, 1-8% or 2-7%, preferably 2-6%, such as 2-5% or 3-4%; the wetting agent is selected from sodium dodecylbenzene sulfonate sulfate; the amount of the wetting agent is 1-10% of the total weight of the formulation, such as 2-9%, 2-8% or 2-7%, preferably 2-6%, such as 3-4% or 2-5%; the filler is selected from one or more of diatomaceous earth, kaolin, white carbon black, light calcium, talc, attapulgite and pottery clay.
[0142] In certain embodiments, the pesticide formulation is a water-dispersible granule, which includes adjuvants, including dispersants, wetting agents, disintegrants and / or binders, etc., and the rest of fillers. Among them, the dispersant is selected from one or two of sodium methyl naphthalene sulfonate formaldehyde condensate and sodium polycarboxylate; the amount of the dispersant is 1-10% of the total weight of the formulation, such as 2-9%, 3-8% or 4-7%, preferably 3-7%, such as 4-6% or 5-6%; the wetting agent is selected from pull open powder BX; the amount of the wetting agent is 1-10% of the total weight of the formulation, such as 1-9%, 2-8% or 2-7%, preferably 2-6%, such as 2-5% or 3-4%; the disintegrant is selected from one or more of sodium carbonate, ammonium sulfate, urea, succinic acid and sodium bicarbonate, etc.; The amount of the disintegrant is 0.1-10% of the total weight of the preparation, such as 1-9%, 1-8%, 1-7% or 1-6%, preferably 1-5%, such as 1-4% or 1-3%; the binder is selected from polyvinyl pyrrolidone; the amount of the binder is 0.1-10% of the total weight of the preparation, such as 1-9%, 2-8%, 1-8%, 1-7% or 1-6%, preferably 1-5%, such as 2-4% or 1-3%; the filler is selected from one or more of diatomaceous earth, kaolin, white carbon black, light calcium, sepiolite, talc, attapulgite and clay.
[0143] In certain embodiments, the total weight of the active ingredients of the pesticide formulation accounts for 1% to 99% of the total weight, for example, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, , 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98 or 99%.
[0144] In certain embodiments, the plant pathogenic bacteria are selected from Xanthomonas oryzae ACCC 11602 and Xanthomonas axonopodis pv. Citri.
[0145] The method of the present invention is described below by means of specific examples. It should be understood that these examples are used to illustrate the basic principles, main features and advantages of the present invention, and the present invention is not limited to the scope of the following examples; the implementation conditions adopted in the examples can be further adjusted according to specific requirements, and the implementation conditions not specified are usually the conditions in routine experiments.
[0146] Unless otherwise stated, the materials used in the examples of this application can be purchased directly from the market.
[0147] Example 1: Preparation of L-2
[0148]
[0149] Place 2g of berberine hydrochloride in a 100mL flask, add a magnetic rod of appropriate size, and heat to 190℃ under vacuum. Cool to room temperature, add 30mL of ethanol-concentrated hydrochloric acid (95:5) solution to the flask, and stir at room temperature for 30min. Filter by suction, wash the filter cake with mother liquor, and dry it to obtain L-2. It can be further purified by column chromatography with dichloromethane: methanol = 2:1.
[0150] Compound L-2: 1 H NMR (400 MHz, DMSO-d 6 )δ: 10.91(s,1H),8.24(s,1H),7.14(s,1H),6.78(s,1H),6.37(d,J=7.8Hz,1H),6.13(s,1H),5.5 1(d,J=7.8Hz,1H),5.26(s,2H),3.65(t,J=6.1Hz,2H),2.89(s,3H),2.20(t,J=6.1Hz,2H).MS-ESI m / z:calcd for C 19 H 16 NO 4 + [M] + :322.3395; found:322.3412.
[0151] Example 2: Preparation of L-5
[0152]
[0153] 10g of berberine hydrochloride and 5N sodium hydroxide aqueous solution were added with 15mL of acetone and stirred at room temperature for 1h. The product was filtered, washed with pure water, and then washed with 20mL of 80% methanol solution to remove acetone, and the product was collected and dried. Intermediate 1 is a yellow solid. 150mg of intermediate 1 (1eq) was dissolved in acetonitrile, 140mg of sodium iodide and 1.5 equivalents of iodomethane were added, and the reaction was carried out at 80°C for 6h. The reaction solution was concentrated and eluted with dichloromethane and methanol system to obtain compound L-5.
[0154] Compound L-5: 1 H NMR (400 MHz, DMSO-d 6 )δ:9.89(s,1H),8.20(s,2H),7.28(s,1H),7.16(s,1H),6.19(s,2H),4.79 (s,2H),4.09(d,J=2.0Hz,6H),3.08(t,J=5.8Hz,2H),1.77(s,3H).MS-ESI m / z:calcd for C 21 H 20 NO 4 + [M] + :350.3935; found:350.5233.
[0155] Example 3: Preparation of L-6
[0156]
[0157] Referring to Example 2, L-6 can be obtained by simply replacing methyl iodide with ethyl iodide.
[0158] Compound L-6: 1 H NMR (400 MHz, DMSO-d 6 )δ:1.45(t,J)7.2Hz,3H),3.08(t,J)5.6Hz,2H),3.35(q,J)7.2Hz,2H),4.09(s,3H),4.09(s,3H),4.81(t,J)5.6Hz,2H ),6.18(s,2H),7.16(s,1H),7.29(s,1H),8.19(d,J)9.2Hz,1H),8.24(d,J)9.6Hz,1H),9.92(s,1H).MS-ESIm / z:calcd for C 22 H 22 NO 4 + [M] + :364.4205; found:364.2468.
[0159] Example 4: Preparation of L-7
[0160]
[0161] Referring to Example 2, L-7 can be obtained by simply replacing methyl iodide with propyl iodide.
[0162] Compound L-7: 1 H NMR: δ: 0.99(t,J)7.2Hz,3H),1.78(q,J)7.2Hz,2H),3.07(t,J)5.6Hz,2H),3.31(m,2H),4.08(s,6H),4.79(t,J)5. 6Hz,2H),6.18(s,2H),7.15(s,1H),7.25(s,1H),8.17(d,J)9.6Hz,1H),8.22(d,J)9.6Hz,1H),9.90(s,1H).MS-ESI m / z:calcd forC 23 H 24 NO 4 + [M] + :378.4475; found:378.2284.
[0163] Example 5: Preparation of L-8
[0164]
[0165] Referring to Example 2, L-8 can be obtained by simply replacing methyl iodide with butyl iodide.
[0166] Compound L-8: 1 H NMR(400MHz,Chloroform-d)δ:10.32(s,1H),7.89(d,J=3.6Hz,1H),7.85(d,J=9.4Hz,1H),7.08(s,1H),6.89(s,1H),6.11(d,J =1.3Hz,2H),4.40(s,3H),4.07(s,3H),3.25(d,J=9.3Hz,2H),3.22(s,2H),1.91(t,J=8.2Hz,2H),1.16(d,J=7.3Hz,5H).MS-ESI m / z:calcd for C 24 H 26 NO 4 + [M] + :392.4745; found:392.2565.
[0167] Example 6: Preparation of L-9
[0168]
[0169] Referring to Example 2, L-9 can be obtained by replacing methyl iodide with isopropyl iodide.
[0170] Compound L-9: 1 H NMR(400MHz,Chloroform-d)δ:10.33(s,1H),7.91(d,J=9.4Hz,1H),7.86(s,1H),7.11(s,1H),6.89(s,1H),6.11(s,2H),5.13(s,2H), 4.41(s,3H),4.08(s,3H),3.31–3.24(m,2H),3.22(t,J=5.9Hz,2H),1.87(t,J=8.2Hz,2H),1.25(s,2H),1.03(t,J=7.3Hz,3H).MS-ESI m / z:calcd for C 23 H 24 NO 4 + [M] + :378.4475; found:378.2296.
[0171] Example 7: Preparation of L-11
[0172]
[0173] Referring to Example 2, L-11 can be obtained by replacing methyl iodide with 1-iodopentane.
[0174] Compound L-11: 1 H NMR(400MHz,DMS0-6)δ:9.85(s,1H),8.17(s,2H),7.24(s,1H),7.13(s,1H),6.15(s,2H),4.76(s,2H),4.06(d,J =3.1Hz,6H),3.31-3.28(m,2H),3.05(s,2H),1.80-1.64(m,2H),1.38-1.24(m,4H),0.83(t,J=7.0Hz,3H).MS-ESI m / z:calcd forC 25 H 28 NO 4 + [M] + :406.5015; found:406.2882.
[0175] Example 8: Preparation of L-12
[0176]
[0177] Referring to Example 2, L-12 can be obtained by simply replacing methyl iodide with 1-iodohexane.
[0178] Compound L-12: 1 H NMR(400MHz,Chloroform-d)δ:10.69(s,1H),7.87(s,1H),7.85(s,1H),7.10(s,1H),6.89(s,1H),6.10(s,2H),5.35(s,2H),4.36(s,3H),4. 07(s,3H),3.31–3.23(m,2H),3.16(t,J=5.8Hz,2H),1.86(t,J=8.4Hz,2H),1.53(s,2H),1.37(p,J=3.7Hz,4H),0.93(d,J=7.0Hz,3H).MS-ESI m / z:calcd for C 26 H 30 NO 4 + [M] + :420.5285; found:420.2590.
[0179] Example 9: Preparation of L-13
[0180]
[0181] Referring to Example 2, only iodomethane is replaced with 1-iodoheptane to obtain L-13.
[0182] Compound L-13: 1 H NMR (400MHz, DMSO-d6) δ: 9.90 (s, 1H), 8.21 (s, 2H), 7.29 (s, 1H), 7.17 (s, 1H), 6.19 (s, 2H), 4.81 (t, J = 5.9Hz, 2H), 4.10 (d, J = 4. 7Hz,6H),3.10(t,J=5.7Hz,2H),2.51(p,J=1.8Hz,2H),1.76(t,J=8.0Hz,2H),1.38–1.22(m,8H),0.85(t,J=6.8Hz,3H).MS-ESI m / z:calcd for C 27 H 32 NO 4 + [M] +:434.5555; found:434.7476.
[0183] Example 10: Preparation of L-14
[0184]
[0185] Referring to Example 2, only iodomethane is replaced with 1-iodoheptane to obtain L-14.
[0186] Compound L-14: 1 H NMR (400MHz, Chloroform-d) δ: 9.90 (s, 1H), 8.23-8.15 (m, 2H), 7.29 (s, 1H), 7.17 (s, 1H), 6.19 (s, 2H), 4.80 (s, 2H), 4.09 (d,J=2.0Hz,6H),3.08(t,J=5.7Hz,2H),1.76(d,J=10.6Hz,2H),1.37(s,2H),1.23(s,10H),0.86(d,J=6.3Hz,3H).MS-ESI m / z:calcd for C 28 H 34 NO 4 + [M] + :448.5825; found:448.8420.
[0187] Example 11: Preparation of L-15
[0188]
[0189] Referring to Example 2, L-15 can be obtained by simply replacing methyl iodide with 1-iodononane.
[0190] Compound L-15: 1 H NMR (400MHz, DMSO) δ: 9.90 (s, 1H), 8.20 (s, 2H), 7.29 (s, 1H), 7.16 (s, 1H), 6.18 (s, 2H), 4.80 (t, J = 5.7Hz, 2H), 4.10 (d, J = 4.7Hz ,6H),3.09(t,J=5.7Hz,2H),1.75(t,J=8.0Hz,2H),1.36(q,J=7.4Hz,2H),1.26(d,J=14.3Hz,8H),0.85(t,J=6.7Hz,5H).MS-ESI m / z:calcd for C 29 H 36 NO 4 + [M]+ :462.6095; found:462.6114.
[0191] Example 12: Preparation of L-16
[0192]
[0193] Referring to Example 2, L-16 can be obtained by replacing methyl iodide with 1-iododecane.
[0194] Compound L-16: 1 H NMR(400MHz,DMSO-d6)δ:9.86(s,IH),8.16(s,2H),7.26(s,IH),7.13(s,IH),6.15(s,2H ), 4.76 (s, 2H), 4.06 (d, J = 2.3Hz, 6H), 3.04 (s, 2H), 1.19 (s, 18H), 0.81 (d, J = 6.9Hz, 3H). MS-ESI m / z:calcd for C 30 H 38 NO 4 + [M] + :476.6365; found:476.6980.
[0195] Example 13: Preparation of L-18
[0196]
[0197] 10g of palmatine hydrochloride and 5N sodium hydroxide aqueous solution were added with 15mL of acetone, and the mixture was stirred at room temperature for 1h. The product was filtered, washed with pure water, and then washed with 20mL of 80% methanol solution to remove acetone. The product was collected and dried. Intermediate 1 is a yellow solid. 150mg of intermediate 1 (1eq) was dissolved in acetonitrile, 140mg of sodium iodide and 1.5 equivalents of p-tert-butylbenzyl bromide were added, and the mixture was reacted at 80°C for 6h. The reaction solution was concentrated and eluted with dichloromethane and methanol system to obtain L-18.
[0198] Compound L-18: 1H NMR (400MHz, DMSO) δ: 10.04 (s, 1H), 8.12 (d, J = 9.4Hz, 1H), 7.83 (d, J = 9.4Hz, 1H), 7.43-7.36 (m, 2H), 7.18-7.10 (m, 3H), 6.97 (s ,1H),4.89(s,2H),4.70(s,2H),4.13(s,3H),4.03(s,3H),3.84(s,3H),3.17(t,J=6.0Hz,2H),2.95(s,3H),1.25(s,9H).MS-ESI m / z:calcd for C 32 H 36 NO 4 + [M] + :498.6425; found:498.6549.
[0199] Example 14: Preparation of F1
[0200]
[0201] Berberine hydrochloride and 5N sodium hydroxide aqueous solution, add 15mL of acetone, and stir at room temperature for 3h. The product is filtered, washed with pure water, and then washed with 20mL of 80% methanol solution to remove acetone, and the product is collected and dried to obtain the intermediate. The intermediate, sodium iodide, and p-tert-butylbenzyl bromide are added to a flask, and an appropriate amount of acetonitrile is added, and the reaction is carried out at 80°C for 3h. The product is purified by column chromatography. The product is dissolved in DMF, reacted at 190°C for 2h, and the DMF is dried to obtain intermediate 2. Intermediate 2 (1eq) and anhydrous potassium carbonate (3eq) are placed in anhydrous dichloromethane. 1.5eq of o-fluorobenzoyl chloride is added under an ice bath, the reaction is moved to room temperature, and the reaction is detected by TLC. Purification by column chromatography obtains F1.
[0202] Compound F1: 1 H NMR(400MHz,Chloroform-d)δ:10.77(s,1H),7.90(dd,J=12.7,8.2Hz,2H),7.77(d,J=9.5Hz,1H),7.55(ddd,J=36.1,13.7,6.6Hz,2H), 7.40(dd,J=12.6,7.6Hz,3H),7.18–7.02(m,5H),6.87(s,1H),6.00(s,2H),4.68(s,2H),3.98(s,3H),3.22(s,2H),1.33(s,9H).MS-ESI m / z:calcd for C 37 H 33 FNO 5+ [M] + :590.6709; found:590.2234.
[0203] Example 15: Preparation of F2
[0204]
[0205] Referring to Example 14, F2 can be obtained by replacing o-fluorobenzoyl chloride with m-fluorobenzoyl chloride.
[0206] Compound F2: 1 H NMR(400MHz,Chloroform-d)δ:10.99(s,1H),8.46(dt,J=7.9,1.2Hz,1H),8.07-8.01 (m,1H),7.89(d,J=9.5Hz,1H),7.78(d,J=9.5Hz,1H),7.58(td,J=8.0,5.5Hz,1H),7.4 -7.37(m,2H),7.33(td,J=8.5,2.8Hz,1H),7.06-7.00(m,3H),6.87(s,1H),6.01(s,2H ),5.30(s,2H),4.68(s,2H),3.97(s,3H),3.47(s,2H),1.33(s,9H).MS-ESIm / z:calcd for C 37 H 33 FNO 5 + [M] + :590.6709; found:590.1042.
[0207] Example 16: Preparation of F3
[0208]
[0209] Referring to Example 14, F3 can be obtained by replacing o-fluorobenzoyl chloride with p-fluorobenzoyl chloride.
[0210] Compound F3: 1H NMR(400MHz,Chloroform-d)δ:10.84(s,1H),8.42(d,J=7.7Hz,1H),8.03(dd,J=8.8,2.4Hz,1 H),7.89(d,J=9.5Hz,1H),7.78(d,J=9.5Hz,1H),7.59(td,J=8.1,5.5Hz,1H),7.39(d,J=8.2Hz ,2H),7.34(dd,J=8.2,2.6Hz,1H),7.09-6.99(m,3H),6.87(s,1H),6.01(s,2H),5.30(s,1H),4 .69(s,2H),4.12(q,J=7.1Hz,0H),3.98(s,3H),3.20(s,2H),1.42(s,1H),1.34(s,9H).MS-ESI m / z:calcd for C 37 H 33 FNO 5 + [M] + :590.6709; found:590.2084.
[0211] Example 17: Preparation of F4
[0212]
[0213] Referring to Example 14, F4 can be obtained by replacing o-fluorobenzoyl chloride with p-chlorobenzoyl chloride.
[0214] Compound F4: 1 H NMR(400MHz,Chloroform-d)δ:10.86(s,1H),8.57(d,J=7.5Hz,1H),8.28(t,J=1.7Hz,1H),7.90(d,J=9.4Hz,1H),7.78(d,J=9.5Hz,1H),7.67-7.54(m,2H) ,7.39(d,J=8.0Hz,2H),7.10-6.98(m,3H),6.87(s,1H),6.01(s,2H),5.30(s, 1H),4.69(s,2H),3.98(s,3H),3.20(s,2H),1.42(s,1H),1.34(s,9H).MS-ESI m / z:calcd forC 37 H 33 ClNO 5 + [M] + :607.1225; found:606.1798.
[0215] Example 18: Preparation of F5
[0216]
[0217] Referring to Example 14, F5 can be obtained by replacing o-fluorobenzoyl chloride with p-chlorobenzoyl chloride.
[0218] Compound F5: 1 H NMR(400MHz,Chloroform-d)δ:10.81(s,1H),8.39(d,J=8.2Hz,2H),7.88(dd,J=9.0,4.1Hz,3H),7.77(d,J=9.5Hz,1H),7.50(d,J=8.2Hz,2H) ,7.40(d,J=1.3Hz,1H),7.11-6.99(m,3H),6.87(s,1H),6.01(s,2H),5 .30(s,1H),4.68(s,2H),3.96(s,3H),3.20(s,2H),1.34(s,9H).MS-ESI m / z:calcd for C 37 H 33 ClNO 5 + [M] + :607.1225; found:606.2059.
[0219] Example 19: Preparation of F6
[0220]
[0221] Referring to Example 14, F6 can be obtained by replacing o-fluorobenzoyl chloride with o-chlorobenzoyl chloride.
[0222] Compound F6: 1 H NMR(400MHz,Chloroform-d)δ:10.64(s,1H),8.82(d,J=7.7Hz,1H),7.98-7.84(m,3H),7.77(d,J=9.4Hz,1H),7.51-7.47(m,1H),7.43(dd,J=5.2,1.9 Hz,3H),7.37(d,J=8.1Hz,1H),7.08-6.99(m,3H),6.87(s,1H),6.01(s,2H ),5.30(s,1H),4.69(s,2H),3.99(s,3H),3.23(s,2H),1.33(s,9H).MS-ESI m / z:calcd for C 37 H 33 ClNO5 + [M] + :607.1225; found:606.2059.
[0223] Example 20: Preparation of F7
[0224]
[0225] Referring to Example 14, F7 can be obtained by replacing o-fluorobenzoyl chloride with p-trifluoromethylbenzoyl chloride.
[0226] Compound F7: 1 H NMR (400MHz, Chloroform-d) δ: 10.98 (s, 1H), 8.65 (d, J = 8.1Hz, 2H), 7.91 (d, J = 9.4Hz, 1H), 7.86 (d, J = 8.2Hz, 2H), 7.80 (d, J = 9.5Hz, 1H), 7.39 (d, J=8.0Hz,2H),7.10-7.01(m,3H),6.87(s,1H),6.02(s,2H),5.30(s,1H), 4.69(s,2H),3.98(s,3H),3.18(s,2H),1.42(s,1H),1.34(s,9H).MS-ESI m / z:calcd for C 38 H 33 F 3 NO 5 + [M] + :640.6787; found:640.1881.
[0227] Example 21: Preparation of F8
[0228]
[0229] Referring to Example 14, F8 can be obtained by replacing o-fluorobenzoyl chloride with p-trifluoromethoxybenzoyl chloride.
[0230] Compound F8: 1H NMR (400MHz, Chloroform-d) δ: 10.80 (s, 1H), 8.62-8.54 (m, 2H), 7.88 (d, J = 9.5Hz, 1H), 7.77 (d, J = 9.5Hz, 1H), 7.41 (dd, J = 15.2, 8. 2Hz,4H),7.03(d,J=9.9Hz,3H),6.87(s,1H),6.02(s,2H),5.30(s,2H),4.68(s,2H),3.97(s,3H),3.19(s,2H),1.34(s,9H).MS-ESI m / z:calcd for C 38 H 33 F 3 NO 6 + [M] + :656.6777; found:656.1835.
[0231] Example 22: Preparation of F9
[0232]
[0233] Referring to Example 14, F9 can be obtained by replacing o-fluorobenzoyl chloride with p-cyanobenzoyl chloride.
[0234] Compound F9: 1 H NMR (400MHz, DMSO) δ: 10.19 (s, 1H), 8.46-8.39 (m, 2H), 8.32-8.17 (m, 3H), 8.14-8.05 (m, 2H), 7.99-7.95 (m, 1H), 7.41 (d, J = 8.1H z,2H),7.17(s,1H),7.03(s,1H),6.09(s,2H),4.83(s,2H),4.77(s,2H),3.99(s,3H),3.16(t,J=5.9Hz,2H),1.28(s,9H).MS-ESI m / z:calcd for C 38 H 33 F 2 NO 5 + [M] + :597.6905; found:597.2310.
[0235] Example 23: Preparation of F10
[0236]
[0237] Referring to Example 14, F10 can be obtained by replacing o-fluorobenzoyl chloride with 2,6-difluorobenzoyl chloride.
[0238] Compound F10: 1 H NMR (400MHz, DMSO) δ: 10.08 (s, 1H), 8.26 (d, J = 9.6Hz, 1H), 8.09 (d, J = 9.5Hz, 1H), 7.89 (tt, J = 8.5, 6.2Hz, 1H), 7.47-7.33 (m, 4H), 7.17 (s, 1H) ,7.12(d,J=7.9Hz,2H),7.03(d,J=6.8Hz,2H),6.09(s,2H),4.84(s,2H),4.77(s,2H),4.03(s,3H),3.16(t,J=6.0Hz,2H),1.27(s,9H).MS-ESI m / z:calcd for C 37 H 32 F 2 NO 5 + [M] + :608.6613; found:608.0153.
[0239] Effect Example 1: Determination of the activity of berberine derivatives against agricultural pathogenic bacteria and its results
[0240] 1) Test agents: berberine derivatives L-2, L-5~L-16, L-18, F1~F10.
[0241] 2) Control drugs: berberine; thiabendazole.
[0242] 3) Test bacteria: The pathogen of rice bacterial blight (Xanthomonas oryzae) ACCC 11602 and the pathogen of citrus canker (Xanthomonas axonopodis pv. Citri) were provided by Gansu Academy of Agricultural Sciences.
[0243] 4) Antimicrobial activity test:
[0244] Preparation of NB solid culture medium: Add 3g beef extract, 5g peptone, 1g yeast powder, 10g sucrose, and 15g agar to a conical flask in sequence, then add 1L distilled water to completely dissolve the mixture, adjust the pH to 7.0, seal the conical flask with tin foil, put it in a high-pressure steam sterilizer at 121°C, sterilize for 20 minutes, and take it out for use. Preparation of plant bacterial NB liquid culture medium: Add 3g beef extract, 5g peptone, 1g yeast powder, and 10g sucrose to a conical flask in sequence, then add 1L distilled water to completely dissolve the mixture, adjust the pH to 7.0, seal the conical flask with tin foil, put it in a high-pressure steam sterilizer at 121°C, sterilize for 20 minutes, and take it out for use.
[0245] Antibacterial activity test method: Take out the plant bacterial strain containing 30% glycerol frozen at -80℃ in the laboratory and place it on a clean bench to thaw the strain. Use a sterile inoculation loop to dip a small amount of thawed bacterial solution, streak it on the plant bacterial NB solid culture medium, and cultivate it in a constant temperature incubator at 28℃ until a single colony grows. Pick the above single colony into the plant bacterial NB liquid culture medium, shake and culture it on a constant temperature shaker (28℃, 180rpm) until the logarithmic growth phase, and dilute the plant bacterial strain with liquid culture medium to 106CFU / mL for use. Weigh 2-4mg of the target compound with an analytical balance, take an appropriate amount of DMSO to dissolve it, and add the solution to the plant bacterial NB liquid culture medium so that the drug concentration in the culture medium is 200μg / mL. Add 50 μL of drug-containing culture medium and 50 μL of bacterial culture (106 CFU / mL) to a 96-well plate, and take 100 μL of bacterial solution of the same concentration as a blank control. Place the 96-well plate in a constant temperature incubator at 28°C and culture for 24-48 hours until the bacterial solution in the blank control group grows. Detect the OD values of the drug-containing bacterial solution and 100 μL of drug-containing culture medium at a specific concentration in the 96-well plate at OD600 on a microplate reader. Each group of experiments was repeated three times in parallel. The calculation formula for the inhibition rate is as follows:
[0246] Corrected blank culture medium OD value = bacterial blank culture medium OD value - sterile blank culture medium OD value
[0247] Corrected drug-containing culture medium OD value = bacteria-containing drug culture medium OD value - sterile drug-containing culture medium OD value
[0248] Inhibition rate = (corrected control culture medium bacterial solution OD value - corrected drug-containing culture medium OD value) / corrected control culture medium bacterial solution OD value × 100%
[0249] The MIC value of the test bacteria is the administration concentration that inhibits 90% bacterial growth compared with the blank control.
[0250] The compound-containing liquid culture medium was diluted by two-fold dilution in a 96-well plate to obtain 50 μL of a series of concentrations of the drug-containing culture medium, and then the inhibition rate corresponding to the series of concentrations was determined according to the same test method as above. All experiments were set up in triplicate to determine the MIC of the compound. 90 The values (the lowest drug concentration that inhibits 90% bacterial growth) are shown in Table 1.
[0251] Table 1 MIC of berberine derivatives L-2, L-5~L-16, L-18, F1~F10 against plant pathogenic bacteria 90 (μg / mL)
[0252]
[0253] From the activity test results in Table 1, it can be seen that the berberine derivatives L-2, L-5 to L-16, L-18, F1 to F10 prepared by the present invention showed different degrees of inhibitory activity against two plant pathogenic bacteria, among which the MIC of L-15 against Xanthomonas oryzae and Xanthomonas citri odoratus was 0. 90 The values all reached 1.56μg / mL, which was significantly better than the control drugs thiabendazole and berberine.
[0254] Dosage Formulation
[0255] Dosage Form Preparation Example 1 30% Compound L-15 Suspension
[0256] Table 2
[0257] Components content(%) Remark Compound L-15 30 Active ingredients Polyoxyethylene polyoxypropylene ether block copolymer sulfate 2.5 Wetting Agents Alkyl naphthalene sulfonate 3.6 First dispersant Phosphate salts 1.9 Second dispersant Glycerol 2 antifreeze Xanthan gum 1 First thickener Magnesium Aluminum Silicate 0.5 Second thickener Casson 1 preservative Tributyl phosphate 0.5 Defoaming agent Deionized water Make up 100 filler
[0258] The laboratory preparation method of 30% compound L-15 suspension is as follows: weigh the wetting agent, dispersant, antifreeze, preservative, defoamer, and deionized water according to the ratio, add them into a beaker and mix them evenly, then add compound L-15 into the beaker, and then transfer it to a sand mill, add zirconium oxide beads into the sand mill, grind for 2-3 hours, add a thickener and continue grinding for 0.5 hours, so that the particle size D95 is controlled below 5 microns, filter to remove the zirconium oxide beads, and the suspension can be obtained.
[0259] Dosage Form Preparation Example 2 20% Compound L-16 Suspension
[0260] Table 3
[0261] Components content(%) Remark Compound L-15 20 Active ingredients Agrilan788 2 The first dispersant, Agrilan1015 3 The second dispersant, Propylene glycol 3 antifreeze Xanthan gum 1 First thickener Magnesium Aluminum Silicate 0.5 Second thickener Casson 1 preservative Silicone 0.5 Defoaming agent Deionized water Make up 100 filler
[0262] (Agrilan788 and Agrilan1015 are provided by Nanjing Jierun Technology Co., Ltd.)
[0263] The laboratory preparation method of 20% compound L-16 suspension is as follows: weigh the wetting agent, dispersant, antifreeze, preservative, defoamer, and deionized water according to the ratio, add them into a beaker and mix them evenly, then add compound L-16 into the beaker, and then transfer it to a sand mill, add zirconium oxide beads into the sand mill, grind for 2-3 hours, add a thickener and continue grinding for 0.5 hours, so that the particle size D95 is controlled below 5 microns, filter to remove the zirconium oxide beads, and the suspension can be obtained.
[0264] Dosage Form Preparation Example 3 30% Compound L-13 Dry Suspension
[0265] Table 4
[0266] Components content(%) Remark Compound L-13 30 Active ingredients Alkylphenol polyoxyethylene ether formaldehyde condensate sulfate 3.2 Wetting Agents 2-Naphthalenesulfonic acid formaldehyde condensate 2.1 First dispersant Sodium lignin sulfonate 1.3 Second dispersant Sodium sulfate 2 Disintegrants Polyethylene glycol 1.8 Binder Tributyl phosphate 0.5 Defoaming agent diatomite Make up 100 filler
[0267] The laboratory preparation method of 30% compound L-13 dry suspension is as follows: weigh the wetting agent, dispersant, filler and water according to the ratio, add them into a beaker and mix them evenly, then add compound L-13 into the beaker, and then transfer it to a sand mill, add zirconium oxide beads into the sand mill, grind for 2-3 hours, control the particle size D95 below 5 microns, filter to remove the zirconium oxide beads, and pump the obtained material into a centrifugal spray dryer for drying and granulation to obtain the product.
[0268] Dosage Form Preparation Example 4 60% Compound L-14 Wettable Powder
[0269] Table 5
[0270] Components content(%) Remark Compound L-14 60 Active ingredients Sodium dodecylbenzenesulfonate 3.2 Wetting Agents Sodium methylnaphthalene sulfonate formaldehyde condensate 2.1 First dispersant Fatty amine polyoxyethylene ether 1.3 Second dispersant White Carbon Black 2 filler Kaolin Make up 100 filler
[0271] The laboratory preparation method of 60% compound L-14 wettable powder is as follows: compound L-14, wetting agent, dispersant and filler are weighed according to the proportion, added into a food processor and mixed evenly, and then put into a jet mill for grinding to obtain the wettable powder.
[0272] Dosage Form Preparation Example 5 40% Compound F4 Water Dispersible Granules
[0273] Table 6
[0274]
[0275]
[0276] The laboratory preparation method of 40% compound F4 water-dispersible granules is as follows: compound F4, wetting agent, dispersant, disintegrant and filler are weighed according to the ratio, added into a food processor and mixed evenly, then put into a jet mill for grinding, mixed again with a food processor, added with an appropriate amount of water, and extruded into granules with a granulator to obtain the granules.
[0277] Dosage Form Preparation Example 6 20% Compound F5 Suspension
[0278] Table 7
[0279] Components content(%) Remark Compound F5 20 Active ingredients Alkylbenzene polyoxyethylene ether phosphate 3.2 Wetting Agents Glyceryl fatty acid ester polyoxyethylene ether 3.6 First dispersant Nonionic hydroxylated polyethylene oxide block copolymer 1.9 Second dispersant Propylene glycol 2 antifreeze Xanthan gum 1 Thickener benzoic acid 1 preservative Silicone 0.5 Defoaming agent Deionized water Make up 100 filler
[0280] The laboratory preparation method of 20% compound F5 suspension is as follows: weigh the wetting agent, dispersant, antifreeze, preservative, defoamer, and deionized water according to the ratio, add them into a beaker and mix them evenly, then add compound F5 into the beaker, and then transfer it to a sand mill, add zirconium oxide beads into the sand mill, grind for 2-3 hours, add a thickener and continue grinding for 0.5 hours, so that the particle size D95 is controlled below 5 microns, filter to remove the zirconium oxide beads, and the suspension can be obtained.
[0281] Dosage Form Preparation Example 7 50% Compound F6 Suspension
[0282] Table 8
[0283]
[0284]
[0285] The laboratory preparation method of 50% compound F6 suspension is as follows: weigh the wetting agent, dispersant, antifreeze, preservative, defoamer, and deionized water according to the ratio, add them into a beaker and mix them evenly, then add compound F5 into the beaker, and then transfer it to a sand mill, add zirconium oxide beads into the sand mill, grind for 2-3 hours, add a thickener and continue grinding for 0.5 hours to control the particle size D95 below 5 microns, filter to remove the zirconium oxide beads, and the suspension can be prepared.
[0286] Preparation of dosage form Comparative Example 1 20% Thiacudazole wettable powder
[0287] Table 9
[0288] Components content(%) Remark Compound L-14 60 Active ingredients Sodium dodecylbenzenesulfonate 3.2 Wetting Agents Sodium methylnaphthalene sulfonate formaldehyde condensate 2.1 First dispersant Fatty amine polyoxyethylene ether 1.3 Second dispersant White Carbon Black 2 filler Kaolin Make up 100 filler
[0289] The laboratory preparation method of 20% thiophene citrate wettable powder is as follows: thiophene citrate, wetting agent, dispersant and filler are weighed according to the proportion, added into a food processor and mixed evenly, and then put into a jet mill to grind.
[0290] Preparation efficacy
[0291] Preparation Effect Example 1 Efficacy of Controlling Rice Bacterial Blight
[0292] 1) Test agents: prepared according to the above preparation example: 30% compound L-13 dry suspension, 60% compound L-14 wettable powder, 20% compound L-15 suspension, 20% compound L-16 suspension, 40% compound F4 water dispersible granules, 20% compound F5 suspension, 50% compound F6 suspension;
[0293] 2) Control drug: 6% zhongshengmycin soluble solution, PD20211959, Fujian Kaili Biological Products Co., Ltd., commercially available.
[0294] 20% thiabendazole wettable powder (prepared in-house according to the formulation preparation control example 1).
[0295] 3) Test method: On May 9, 2023, 15-20 germinated seeds were placed in each pot of soil, and when the rice seedlings grew to 2-3 leaves, they were set aside. The leaf cutting method was used to test the biological activity of each agent against rice bacterial blight in vivo. First, 100 μg / mL of each agent was evenly sprayed on the rice leaves until the solution dripped. Inoculate the bacteria 24 hours after spraying. When inoculating, use sterilized scissors to dip the bacterial solution containing rice bacterial blight and inoculate it on each pot of rice plants. After spraying an equal amount of dimethyl sulfoxide aqueous solution without adding agents for 24 hours, use sterilized scissors to dip the bacteria and cut the leaves for inoculation. Each treatment has 3 replicates, for a total of 9 pots; record the length and total length of the lesions on the rice leaves, and calculate the disease index and prevention effect according to the grading standards. The grading standards are as follows:
[0296] Grade 0: No disease;
[0297] Level 1: The leaf lesion area accounts for less than 10% of the leaf area;
[0298] Level 3: The leaf lesions account for 11-25% of the leaf area;
[0299] Level 5: The leaf lesions account for 26-45% of the leaf area;
[0300] Level 7: The leaf lesions account for 46-65% of the leaf area;
[0301] Level 9: The leaf spot area accounts for more than 65% of the leaf area.
[0302] Disease index (%) = [∑ (number of diseased leaves at each level × representative value at each level) / (total number of leaves surveyed × highest representative value)] × 100.
[0303] Relative efficacy (%) = (control disease index - treatment disease index) / control disease index × 100
[0304] Table 10 Results of indoor pot experiment on prevention and control of rice bacterial blight
[0305] Test drug Disease index Relative efficacy (%) 30% Compound L-13 dry suspension 13.21 66.07 60% Compound L-14 wettable powder 13.40 65.60 20% Compound L-15 suspension 11.16 71.34 20% Compound L-16 Suspension 13.58 65.12 40% Compound F4 water dispersible granules 13.52 65.28 20% Compound F5 Suspension 13.65 64.95 50% Compound F6 Suspension 13.96 64.14 20% Thiacandazole wettable powder 22.52 42.15 3% Zhongshengmycin wettable powder 21.48 44.84 Blank control 38.93 /
[0306] Preparation Effect Example 2 Efficacy of preventing and treating citrus canker
[0307] 1) Test agents: 30% compound L-13 dry suspension, 60% compound L-14 wettable powder, 20% compound L-15 suspension, 20% compound L-16 suspension, 40% compound F4 water dispersible granules, 20% compound F5 suspension, 50% compound F6 suspension;
[0308] 2) Control agent: 30% thiamethoxam suspension, registration number PD20142170, Zhejiang Dongfeng Chemical Co., Ltd., purchased from the market;
[0309] 3) Blank control: clean water;
[0310] 4) Experimental base and citrus varieties: The experimental site is located in the Wogan base in the suburb of Xiaopingyang, Laibin, Guangxi. The soil fertility is average and the base is flat. The test variety is Wogan, 3 years old, with a row spacing of 4m×3m and an average plant height of 1.5m.
[0311] 5) Experimental design and methods: A field efficacy test on Wogan canker was conducted in the suburbs of Xiaopingyang, Laibin, Guangxi. Eight treatment plots were set up, and the treatment plots were arranged in random blocks. 12 Wogan trees were listed in each treatment plot, and repeated 3 times. The pesticide was applied during the autumn shoot period, spraying once every 7-10 days. The specific spraying time was September 2, September 9, and September 16. Easy Spray (capacity 16 kg) was used for spraying. The dosage is shown in Table 2-1. The blank control group was sprayed with clean water, and no pesticide was used. The weather during the spraying period was sunny or cloudy.
[0312] 6) Investigation method: Observe and record the occurrence of leaf canker on the 3rd and 10th days after each spraying, investigate the prevention effect 20 days after the last spraying, and record relevant data. In each treatment plot, 5 trees were surveyed, and samples were taken from 5 points in the east, south, west, north, and center of each tree. Two treetops were randomly surveyed at each point, and 10 leaves were pinned from each tree to record the number of diseased leaves at each level.
[0313] The grade of Wogan canker is divided according to the number of lesions on a single leaf. The grading standards are as follows:
[0314] Level 0: no disease;
[0315] Level 1: 1-5 lesions on each leaf;
[0316] Level 3: 6-10 lesions on each leaf;
[0317] Level 5: 11-15 lesions on each leaf;
[0318] Level 7: 16-20 lesions on each leaf;
[0319] Level 9: There are more than 21 lesions on each leaf.
[0320] The disease index and prevention efficacy were calculated according to formulas (1)-(2):
[0321] Disease index (%) = [∑ (number of diseased leaves at each level × representative value at each level) / (total number of leaves surveyed × highest representative value)] × 100.
[0322] Relative control effect (%) = (disease index of blank control area after application - disease index of treated area after application) / disease index of blank control area after application × 100.
[0323] Table 11 Field efficacy test results for preventing and controlling Wogan canker
[0324] Test drug Dilution multiple Disease index Relative efficacy (%) 30% Compound L-13 dry suspension 500 2.00 86.07 60% Compound L-14 wettable powder 1000 1.76 87.72 30% Compound L-15 suspension 500 1.23 91.43 20% Compound L-16 Suspension 600 2.16 84.93 40% Compound F4 water dispersible granules 800 2.13 85.14 20% Compound F5 Suspension 300 2.21 84.57 50% Compound F6 Suspension 900 2.19 84.78 30% Thiam copper suspension 300 3.01 79.05 Blank control 14.36 /
[0325] As shown in Table 11, the efficacy of the preparations of compounds L-13 to L-16 and compounds F4 to F6 in preventing and treating citrus ulcer disease is significantly better than that of 30% thiamethoxam copper suspension, which is a better agent for preventing and treating ulcer disease on the market.
[0326] In summary, the diphenylethylene derivatives of the present invention show good antibacterial activity against the pathogens of rice bacterial blight, citrus canker, tomato bacterial wilt and soft rot, and can be further studied and developed in the prevention and control of plant pathogenic bacteria.
[0327] It should be understood that the above embodiments are exemplary and are not intended to include all possible implementations included in the claims. Various modifications and changes may be made on the basis of the above embodiments without departing from the scope of the present disclosure. Similarly, the various technical features of the above embodiments may be arbitrarily combined to form other embodiments of the present invention that may not be explicitly described. Therefore, the above embodiments only express several implementations of the present invention and do not limit the scope of protection of the patent of the present invention.
Claims
1. Use of the compound represented by formula (I) or its stereoisomers, solvates, hydrates, stable isotope derivatives and pesticide-acceptable salts in the preparation of pesticides for preventing, alleviating and / or treating diseases caused by plant pathogenic bacteria: in: R1 and R2 are each independently selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl; or R1 and R2 and the atoms to which they are attached form a heterocyclic group or a heteroaryl group; R3 is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally replaced by one or more R 3a replace; R4 is selected from H, D, halogen, mercapto, hydroxyl, nitro, cyano, aldehyde, alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino, hydroxyalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the aldehyde, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally replaced by one or more R 4a replace; A - is selected from a counter anion; The R 3a is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted by one or more R 3b replace; The R 4a is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl, wherein the alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally substituted by one or more R 4b replace; The R 3b is selected from H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl; The R 4b is selected from the group consisting of H, D, halogen, mercapto, hydroxy, nitro, cyano, oxo, alkyl, alkoxy, haloalkyl, haloalkoxy, cycloalkyl, heterocyclyl, aryl and heteroaryl; Provided that the compound represented by the formula (I) is not 2. The use according to claim 1, characterized in that The R1 and R2 are each independently selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl; preferably selected from H, D, halogen, mercapto, hydroxyl, nitro, cyano, C 1-3 Alkyl and C 1-3 Alkoxy; more preferably selected from H, D and C 1-3 Alkoxy; most preferably selected from methoxy; Or the R1 and R2 and the atoms connected thereto form a 3-10 membered heterocyclic group or a 5-14 membered heteroaryl group; preferably a 5-10 membered heterocyclic group or a 5-10 membered heteroaryl group, wherein the 5-10 membered heterocyclic group and the 5-10 membered heteroaryl group contain 1-4 heteroatoms selected from N, O and S; more preferably a 5-6 membered heterocyclic group, wherein the 5-6 membered heterocyclic group contains 1-2 heteroatoms selected from O; most preferably a dioxolane group.
3. The use according to claim 1 or 2, characterized in that: R3 is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, C 1-20 Alkyl, C 1-20 Alkoxy, C 3-10 Cycloalkyl, 3-10 membered heterocyclic group, C 6-14 Aryl and 5-14 membered heteroaryl, the C 1-20 Alkyl, C 1-20 Alkoxy, C 3-10 Cycloalkyl, 3-10 membered heterocyclic group, C 6-14 Aryl and 5-14 membered heteroaryl are optionally substituted by one or more R 3a Substituted; preferably selected from H, D, halogen, mercapto, hydroxyl, nitro, cyano, C 1-10 Alkyl and C 1-10 Alkoxy, the C 1-10 Alkyl and C 1-10 The alkoxy group is optionally substituted with one or more R 3a substituted; more preferably selected from H, D and C 1-10 Alkyl, the C 1-10 The alkyl group is optionally substituted with one or more R 3a substituted; most preferably selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl and n-hexyl, wherein the methyl, ethyl, n-propyl, isopropyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl and n-hexyl are optionally substituted with one or more R 3a replace.
4. The use according to any one of claims 1 to 3, characterized in that: The R 3a is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, oxo, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl, the C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl are optionally substituted by one or more R 3b Substituted; preferably selected from H, D, halogen, mercapto, hydroxyl, nitro, cyano, C 1-6 Alkyl and C 6-10 Aryl, the C 1-6 Alkyl and C 6-10 The aryl group is optionally substituted with one or more R 3b substituted; more preferably selected from H, D and C 6-8 Aryl, the C 6-8 The aryl group is optionally substituted with one or more R 3b substituted; most preferably selected from H and phenyl, the phenyl group optionally being substituted with one or more R 3b replace.
5. The use according to any one of claims 1 to 4, characterized in that: The R 3b is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, oxo, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl; preferably selected from H, D, halogen, mercapto, hydroxyl, nitro, cyano and C 1-6 Alkyl; more preferably selected from H, D and C 1-4 Alkyl; most preferably selected from H and tert-butyl.
6. The use according to any one of claims 1 to 5, characterized in that: The R4 is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, aldehyde, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 3-10 membered heterocyclic group, C 6-14 Aryl and 5-14 membered heteroaryl, the aldehyde group, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 3-10 membered heterocyclic group, C 6-14 Aryl and 5-14 membered heteroaryl are optionally substituted by one or more R 4a Substituted; preferably selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, aldehyde and C 1-6 Alkyl, the aldehyde group and C 1-6 The alkyl group is optionally substituted with one or more R 4a Substituted; more preferably selected from H, D, aldehyde and C 1-3 Alkyl, the aldehyde group and C 1-3 The alkyl group is optionally substituted with one or more R 4a Substituted; most preferably selected from H, methyl and aldehyde groups, the methyl and aldehyde groups are optionally replaced by one or more R 4a replace.
7. The use according to any one of claims 1 to 6, characterized in that: The R 4a is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, oxo, C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl, the C 1-6 Alkyl, C 1-6 Alkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl are optionally substituted by one or more R 4b Substituted; preferably selected from H, D, halogen, mercapto, hydroxyl, nitro, cyano, C 1-6 Alkyl and C 6-10 Aryl, the C 1-6 Alkyl and C 6-10 The aryl group is optionally substituted with one or more R 4b substituted; more preferably selected from H, D and C 6-8 Aryl, the C 6-8 The aryl group is optionally substituted with one or more R 4b substituted; most preferably selected from H and phenyl, the phenyl group optionally being substituted with one or more R 4b replace.
8. The use according to any one of claims 1 to 7, characterized in that The R 4b is selected from H, D, halogen, thiol, hydroxyl, nitro, cyano, oxo, C 1-6 Alkyl, C 1-6 Alkoxy, C 1-6 Haloalkyl, C 1-6 Haloalkoxy, C 3-7 Cycloalkyl, 5-10 membered heterocyclic group, C 6-10 Aryl and 5-10 membered heteroaryl; preferably selected from H, D, halogen, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, C 1-6 Haloalkyl and C 1-6 more preferably selected from H, D, halogen, cyano, C 1-3 Haloalkyl and C 1-3 Haloalkoxy; most preferably selected from H, F, Cl, cyano, trifluoromethyl and trifluoromethoxy.
9. The use according to any one of claims 1 to 8, characterized in that The A - Selected from halide, alkyl sulfate, alkyl sulfonate, phosphate, sulfate, bisulfate, lactate, glycolate, acetate and citrate; preferably selected from halide, methyl sulfate, ethyl sulfate, methyl sulfonate, phosphate, sulfate, bisulfate, lactate, glycolate, acetate and citrate; more preferably selected from chloride, bromide, iodide, phosphate, sulfate and bisulfate; most preferably selected from chloride.
10. The use according to any one of claims 1 to 9, characterized in that: The compound represented by formula (I) is any one of the following:
11. Use of a pesticide composition for preventing, alleviating and / or treating diseases caused by plant pathogenic bacteria, characterized in that: The pesticide composition comprises the compound represented by formula (I) or its stereoisomer, solvate, hydrate, stable isotope derivative and pesticide-acceptable salt for use as described in any one of claims 1 to 10, and a pesticide-acceptable carrier.
12. Use of a pesticide formulation for preventing, alleviating and / or treating diseases caused by plant pathogenic bacteria, characterized in that: The pesticide preparation comprises the compound represented by formula (I) or its stereoisomer, solvate, hydrate, stable isotope derivative and pesticide-acceptable salt for use as claimed in any one of claims 1 to 10, or the pesticide composition for use as claimed in claim 11; Preferably, the pesticide formulation is a suspension concentrate, a dry suspension concentrate, a wettable powder or a water dispersible granule.
13. The use according to any one of claims 1 to 12, characterized in that The plant pathogenic bacteria are selected from the group consisting of Xanthomonas oryzae ACCC 11602 and Xanthomonas axonopodis pv. Citri.
